FR2113949A1 - Compsns contg l-dopa and an alpha hydrazinyl propionic - acid - for treatment of hypertension - Google Patents

Compsns contg l-dopa and an alpha hydrazinyl propionic - acid - for treatment of hypertension

Info

Publication number
FR2113949A1
FR2113949A1 FR7140574A FR7140574A FR2113949A1 FR 2113949 A1 FR2113949 A1 FR 2113949A1 FR 7140574 A FR7140574 A FR 7140574A FR 7140574 A FR7140574 A FR 7140574A FR 2113949 A1 FR2113949 A1 FR 2113949A1
Authority
FR
France
Prior art keywords
hydrazinyl
dopa
hypertension
propionic
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7140574A
Other languages
French (fr)
Other versions
FR2113949B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck et Cie
Merck and Co Inc
Original Assignee
Merck et Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck et Cie, Merck and Co Inc filed Critical Merck et Cie
Publication of FR2113949A1 publication Critical patent/FR2113949A1/en
Application granted granted Critical
Publication of FR2113949B1 publication Critical patent/FR2113949B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Title compsns. contain (I) and (II) where R = H (D, L or DL-isomer) or C1-C4 alkyl (L-isomer). Ratio (I) : (II) is 0.1-25 pref. 0.5-6 by weight.
FR7140574A 1970-11-12 1971-11-12 Compsns contg l-dopa and an alpha hydrazinyl propionic - acid - for treatment of hypertension Granted FR2113949A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8910470A 1970-11-12 1970-11-12

Publications (2)

Publication Number Publication Date
FR2113949A1 true FR2113949A1 (en) 1972-06-30
FR2113949B1 FR2113949B1 (en) 1974-11-15

Family

ID=22215714

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7140574A Granted FR2113949A1 (en) 1970-11-12 1971-11-12 Compsns contg l-dopa and an alpha hydrazinyl propionic - acid - for treatment of hypertension

Country Status (2)

Country Link
AU (1) AU464903B2 (en)
FR (1) FR2113949A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2320738A1 (en) * 1975-08-13 1977-03-11 Merck & Co Inc PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERTENSION
FR2340732A1 (en) * 1976-02-13 1977-09-09 Merck & Co Inc NEW ANTI-HYPERTENSIVE COMPOSITIONS CONTAINING ALANINE DERIVATIVES

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2019605A1 (en) * 1968-10-01 1970-07-03 Merck & Co Inc

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2019605A1 (en) * 1968-10-01 1970-07-03 Merck & Co Inc

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2320738A1 (en) * 1975-08-13 1977-03-11 Merck & Co Inc PHARMACEUTICAL COMPOSITIONS FOR TREATING HYPERTENSION
FR2340732A1 (en) * 1976-02-13 1977-09-09 Merck & Co Inc NEW ANTI-HYPERTENSIVE COMPOSITIONS CONTAINING ALANINE DERIVATIVES

Also Published As

Publication number Publication date
AU3526471A (en) 1973-05-10
AU464903B2 (en) 1975-09-11
FR2113949B1 (en) 1974-11-15

Similar Documents

Publication Publication Date Title
ES405663A1 (en) Aromatic substituted pyrazola {8 1,5a{9 {0 pyrimidine compounds useful as xanthine oxidase inhibitors
ES438931A1 (en) Compositions for treatment of cardiovascular conditions associated with overproduction of catecholamines
FR2113949A1 (en) Compsns contg l-dopa and an alpha hydrazinyl propionic - acid - for treatment of hypertension
FR2082097A5 (en) Evaporated sea water - use in food as a source of trace elements
AT306051B (en) Process for the preparation of storage-stable reduced nicotinamide adenine dinucleotide NADH
JPS5264580A (en) Sequence controller
BE769798A (en) PREPARATION OF CYCLOHEXYL HYDROPEROXIDE BY OXIDATION OF CYCLOHEXAN
ES451301A1 (en) Setting retarder
GB1511196A (en) Creatinine pyrolidonecarboxylate
GB1434194A (en) Substituted furenidones and their use as flavouring agents
CH531832A (en) 1-pentyloxymethyl-2,4,5-trichlorimadazoleant
FR2042290A1 (en) Compositions containing uridine 5 diphospho- - glucose for treatment of liver disorders
FR2124101A1 (en) Sleep-inducing compns contng salicylamide - and glyceryl guaiacolate
GB1071538A (en) Composition and process
FR2152377A1 (en) 1-phenyl-2-methyl-5-alkyl or alkoxy-3-indolylacetic acid - derivs - antiinflammatory, analgesic, antipyretic
NL7006233A (en) Preservation of timber
FR2013814A1 (en) Appetite inhibiting p acetyl phenethylamines
FR2041658A5 (en) Biochemical prodn of lysine by mutant - bacteria
GB1304300A (en)
GB1298057A (en) Bis(aminoalkylsulphamoyl)anthraquinones
FR2116313A1 (en) Protokylol pamoate - with long-acting bronchodilator activity
NL7402745A (en) N-(2-carbamoylvinyl)aminoacids - N-protection of aminoacids by reaction with aminocarbonyl-acetone derivs
FR2160246A1 (en) Tannin/methylcellulose compsns - dermatological antiseptics
BE800792A (en) Subst cyclopentene-alkanoic acid derivs - with hypotensive ulcer-inhibiting and smooth muscle stimulant activity
FR2035718A5 (en) Preparation of thiamine monothiocyanate - and its hydrochloride

Legal Events

Date Code Title Description
ST Notification of lapse